These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. OTA report exposes weaknesses of federal research on medical effectiveness. Am J Health Syst Pharm; 1995 Mar; 52(5):453, 456-7. PubMed ID: 7606543 [No Abstract] [Full Text] [Related]
65. Clinical trials from a regulator's perspective. Lumpkin MM Infection; 1994; 22 Suppl 1():S61-4. PubMed ID: 8050801 [No Abstract] [Full Text] [Related]
66. The Coronary Drug Project. Organizational structure of the study. Canner PL; Stamler J Control Clin Trials; 1983 Dec; 4(4):333-43. PubMed ID: 6675888 [No Abstract] [Full Text] [Related]
67. The Coronary Drug Project. Role and methods of the clinical centers. Berge KG; Laubach CA; Hutchinson RG Control Clin Trials; 1983 Dec; 4(4):419-27. PubMed ID: 6675893 [No Abstract] [Full Text] [Related]
68. The Coronary Drug Project. Closing down the study. Krol WF Control Clin Trials; 1983 Dec; 4(4):505-12. PubMed ID: 6675898 [No Abstract] [Full Text] [Related]
69. Weighing up NICE against private health-care schemes. Gibson TA Nature; 2009 Oct; 461(7268):1198. PubMed ID: 19865141 [No Abstract] [Full Text] [Related]
70. Keep digging until we get the result we want? Berger VW Contemp Clin Trials; 2012 Jan; 33(1):12. PubMed ID: 22001359 [No Abstract] [Full Text] [Related]
72. Disease modification in OA - will we ever get there? Lohmander LS; Roos EM Nat Rev Rheumatol; 2019 Mar; 15(3):133-135. PubMed ID: 30733580 [No Abstract] [Full Text] [Related]
73. Meta-analysis. Neff S Ann Intern Med; 1987 Nov; 107(5):791. PubMed ID: 3116905 [No Abstract] [Full Text] [Related]
74. [Cost-effectiveness analysis of treatment options using the "number-needed-to-treat"]. Catalá-López F Med Clin (Barc); 2014 Apr; 142(7):330-1. PubMed ID: 24268910 [No Abstract] [Full Text] [Related]